Post Categories
Blog post not found!
From Shark Tank to Pharmaceuticals: Billionaire Mark Cuban Makes a Leap for Affordable Medicines
April 4, 2022
Mark Cuban is spearheading an effort to widen Americans’ access to generic pharmaceuticals, adding a direct-to-consumer online pharmacy to the Mark Cuban Cost Plus…
How Can Guidelines Keep Pace with Science? “Living Evidence” May Help
March 28, 2022
Traditionally, the review and updating of medical guidelines have relied on a “systematic review” – a publication following a formal synthesis of data from…
New Draft FDA Guidance on ADC Pharmacology
March 23, 2022
The market for antibody-drug conjugates, or ADCs, is hotter than ever before. In response, the Food and Drug Administration (FDA) released new guidance on clinical…
Lilly/Entos Deal Reinforces the Significance of Delivery Mechanisms for Nucleic Acid-Based Therapies
March 21, 2022
As part of a research partnership aimed at improving the delivery of nucleic acid-based therapies targeting nervous system diseases, American pharmaceutical company Eli Lilly…
Gene Deserts May Hold an Oasis — a Cure for HIV
March 14, 2022
In human cells infected by the human immunodeficiency virus (HIV), virus particles can leave behind part of their genetic material, which gets incorporated into…
New AstraZeneca Drug for HER2-Low Breast Cancer Aces Phase III Trial
March 9, 2022
Infographics Not all cancer cases are created equal. As the medical community hones in on better, less invasive cancer treatments, differentiating between different types…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
